1. Home
  2. WS vs NBTX Comparison

WS vs NBTX Comparison

Compare WS & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Steel Inc.

WS

Worthington Steel Inc.

HOLD

Current Price

$35.39

Market Cap

2.0B

Sector

N/A

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$35.60

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WS
NBTX
Founded
1955
2003
Country
United States
France
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
WS
NBTX
Price
$35.39
$35.60
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$42.50
$36.00
AVG Volume (30 Days)
396.2K
80.4K
Earning Date
03-25-2026
03-31-2026
Dividend Yield
1.76%
N/A
EPS Growth
N/A
N/A
EPS
1.30
N/A
Revenue
$3,093,300,000.00
N/A
Revenue This Year
$16.77
$58.17
Revenue Next Year
$2.69
N/A
P/E Ratio
$27.11
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.22
$4.93
52 Week High
$49.17
$57.14

Technical Indicators

Market Signals
Indicator
WS
NBTX
Relative Strength Index (RSI) 48.21 43.42
Support Level $34.33 $30.15
Resistance Level $36.96 $38.29
Average True Range (ATR) 1.30 2.57
MACD 0.40 -0.17
Stochastic Oscillator 91.38 9.47

Price Performance

Historical Comparison
WS
NBTX

About WS Worthington Steel Inc.

Worthington Steel Inc is a processor of carbon flat-rolled steel, a producer of laser-welded solutions, and a provider of electrical steel laminations. The company has manufacturing facilities across the United States, Canada, China, India, Germany and Mexico. It buys coils of steel from primary steel producers and processes them to precise type, thickness, length, width, shape, and surface quality required by customer specifications. The company's product lines and processing capabilities include; carbon flat-rolled steel processing, electrical steel laminations, and tailor welded products. Geographically, the company generates a majority of its revenue from the United States followed by Canada, Mexico, and other regions.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: